Author:
Idrees Muhammad,Riazuddin Sheikh
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Leiveven J: Pegasys/RBV Improves Fibrosis in Responders, relapsers & Nonresponders with Advanced Fibrosis. 55th Annual Meeting of the American Association for the Study of Liver Disease:. 2004, October 29 – November 2: Boston, MA, USA
2. Zein NN, Persing DH: Hepatitis C Genotypes: current trends and future implications. Mayo Clin Proc. 1996, 71: 458-462.
3. Liew M, Erali M, Page S, Hillyard D, Wittwer C: Hepatitis C Genotyping by Denaturing High-Performance Liquid Chromatography. J Clin Microbiol. 2004, 42 (1): 158-163. 10.1128/JCM.42.1.158-163.2004.
4. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH: Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med. 1996, 125: 634-639.
5. Trepo C: Seminar on hepatitis C. European Commission Public Health Unit. 1994